期刊文献+

酪氨酸激酶Etk/BMX对鼻咽癌细胞放射敏感性的影响

Effects of Tyrosine Kinase Etk/BMX on Radiosensitivity of Nasopharyngeal Carcinoma Cell Lines
下载PDF
导出
摘要 目的研究酪氨酸激酶Etk/BMX对鼻咽癌细胞放射敏感性的影响并探讨其可能机制。方法利用脂质体2000将野生型酪氨酸激酶Etk/BMX表达质粒pcDNA3.0-Etk导入Etk/BMX低表达水平的鼻咽癌细胞株Sune-1中,建立Etk/BMX稳定高表达细胞株Sune-wt,空质粒pcDNA3.0转染细胞作为对照(Sune-vector)。X射线(0、2、4、10、15Gy)照射后,MTT法测定细胞的生存分数(sur-vival fraction,SF);流式细胞术检测细胞的凋亡率、细胞周期、增殖指数以及凋亡相关蛋白p53和bcl-2的变化情况。结果不同剂量X线照射后Sune-wt较Sune-1和Sune-vector生存分数(SF)均显著增高而凋亡均显著减少(P<0.05),累计剂量15Gy后出现明显S、G2期阻滞,增殖指数增高。Sune-wt照射前后p53和bcl-2的表达水平出现显著改变(P<0.05)。结论 Etk/BMX有增强鼻咽癌细胞对放射线的抵抗作用,其可能是通过调控p53和bcl-2的表达以及引起S、G2期阻滞两种途径实现的。 Objective To study the relationship between the tyrosine kinases Etk/BMX and radiosensitivity in nasopharyngeal carcinoma (NPC) cells.Methods Recombinant plasmid pcDNA3.0-Etk was transfected into Sune-1,and Etk was highly expressed in the transfeced cell line Sune-wt.After 0,2,4,10,15Gy X ray radiation,MTT was used to measure survival fraction(SF) and flow cytometer (FCM) assay to examine cell apoptosis rate,cell cycle,proliferation index(PI),and apoptosis-related protein p53 and bcl-2.Results After different X ray radiations the survival fraction of Sune-wt were all higher than those of Sune-1 and Sune-vector(P〈0.05). The cell apoptosis rate of Sune-wt were all dramatically lower than those of Sune-1 and Sune-vector(P〈0.05).There was S,G2 phase blockage and highly up-regulated of proliferation index in Sune-wt after 15 Gy irradiation dosages.Moreover,there were significantly different expression of p53 and bcl-2 in Sune-wt after 15Gy irradiation (P〈0.05).Conclusions This study suggested that Etk/BMX played an important role in protecting nasopharyngeal carcinoma cells from X ray irradiation.Its mechanics may be ralated to p53 and bcl-2 changing and S,G2 phase blockage.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第7期754-758,共5页 Cancer Research on Prevention and Treatment
基金 广东省自然科学基金资助项目(020061)
关键词 鼻咽癌 Etk/BMX 放射敏感性 Nasopharyngeal carcinoma Etk/BMX Radiosensitivity
  • 相关文献

参考文献14

  • 1Mano H. Tec family of protein-tyrosine kinases: an overview of their structure and function[J]. Cytokine Growth Factor Rev, 1999,10(3-4) :267-280.
  • 2Xie Y, Xu K, Dai B, et al. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs[J]. Oncogene, 2006,25 ( 1 ) : 70-78.
  • 3Bagheri-Yarmand R, Mandal M, Taludker AH, et al. Etk/ Bmx tyrosine kinase activates Pakl and regulates tumorigenici ty of breast cancer cells[J]. J Biol Chem, 2001,276 (31): 29403-29409.
  • 4Xue LY, Qiu Y, He J, et al. Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin[J]. 1999, 18 (22) :3391-3398.
  • 5Guo L, Guo Y, Xiao S. Expression of Etk/Bmx tyrosine kinase in the tumorigenicity of naso-pharyngeal epithelium and its relation with EB virus infection and the apoptosis-related protein Bcl 2[J]. Cancer letters, 2006,232(2):255-261.
  • 6Wu YM, Huang CL, Kung HJ, et al. Proteolytic activation of ETK/Bmx tyrosine kinase by caspases[J]. J Biol Chem, 2001, 276(21 ) : 17672-17678.
  • 7Wen X, Lin HH, Shih HM, et al. Kinase activation of the non-receptor tyrosine kinase Etk/BMX alone is sufficient to transactivate STAT-mediated gene expression in salivary and lung epithelia1 cells[J]. J Biol Chem, 1999, 274 (53) : 38204- 38210.
  • 8Wasserman TH, Twentyman P. Use of a colorimetric microtiter (MTT) assay in determining the radiosensitivity of cells from murine solid tumors[J]. Int J Radiat Oncol Biol Phys, 1988,15(3) :699-702.
  • 9Miyashita T, Kitada S, Krajewski S, et al. Overexpression of the Bcl-2 protein increases the half life of p21Bax[J]. J Biol Chem, 1995,270 (44) : 26049-26052.
  • 10Oda E, Ohki R, Murasawa H, et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis[J]. Science, 2000,288 (5468) : 1053-1058.

二级参考文献22

  • 1Pelka P, Ablack JN, Torehia J, et al. Transcriptional control by adenovirus EIA conserved region 3 via p300/CBP [ J]. Nucleic Acids Res, 2009, 37(4) : 1095-1106.
  • 2Stoff-Khalih MA, Dall P, Curiel DT. Gene therapy for carcinoma of the breast [J]. Cancer Gene Ther, 2006, 13(7) : 633-647.
  • 3Zhou RR, Jia SF, Zhou Z. Adenovirus-EIA gene therapy enhances the in vivo sensitivity of Ewing' s sarcoma to VP-16 [J]. Cancer Gene Ther, 2002, 9(5 ) : 407-413.
  • 4Mirza A, Mcguirk M, Hockenberry TN, et al. Human survivin is negalively regulated by wile-type p53 and participates in p53-dependent apoptotic pathway [ J]. Oncogene, 2002, 21 ( 17 ) : 2613-2622.
  • 5Nakajima T, Morita K, Ohi N, et al. Degradation of topoisomerase Ⅱα during adenovirus E1A-induced apoptosis is mediated by the activation of the ubiquitin proteolysis system [J]. J Biol Chem, 1996, 271 ( 11 ) : 24842-24849.
  • 6Somasundaram K, El-Deiry WS. Inhibition of p53-mediated transactivation and cell cycle arrest by El A through its p300/CBP2 interacting region [J]. Oncogene, 1997, 14(20): 1047-1057.
  • 7Timo S, Thomas DB. Adenovirus type 5 early region 1B 156R protein promotes cell transformation independently of repression of p53-stimulated transcription [ J ]. J Virol, 2007, 81 ( 1 ) : 95- 105.
  • 8Daniel AK, Ke L, Jason SK, et al. Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1[J]. J Virol, 2005,79 (15) : 9714-9724.
  • 9Miller DL, Myers CL, Rickards B, et al. Adenovirus type 5 exerts genome-wide control over cellular programs governing proliferation, quiescence, and survival [ J]. Genome Biol, 2007, 8 (4) : R58.
  • 10Yoo GH, Hung MC, Lopez-Berestein G, et al. Phase Ⅰ trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer [J]. Clin Cancer Res, 2001, 7 (5) : 1237-1245.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部